STAAB THOMAS R II (Chief Financial Officer) purchased 56.8% of their position (5.67K shares) of TENAX THERAPEUTICS, INC. on the open market
Open‑market purchase worth $11.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/16/2026ACC: 0001193125-26-392319
Officer· Chief Financial Officer
Since May 2026
+5.67K
Net shares
Net buyer
$11.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.67K
Price / share
$1.94
Trade value
$10.98K
% of position
56.8%
9/11/2026
10K→15.68K
Total
Net shares
+5.67K
Net value
$10.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2026 | P · Purchase | +5.67K | $1.94 | $10.98K | 56.8% | 10K | 15.68K |
| Total | +5.67K | $10.98K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
450K
Shares owned
450K
Exercise price
11.95
Expiration
—
Exercise window
—
Total
Underlying
450K
Owned
450K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 11.95 | — | — | 450K | 450K |
| Total | 450K | 450K | ||||